Watch Ticker

Prelude Therapeutics Incorporated

Go to Prelude Therapeutics Incorporated Website

$0.85

0.00 (0.00%)

Live

Previous Close

$0.8498

Day Range

$0 - $0

Previous Day Range

$0.82 - $0.8689

Market Cap

$47.5 million USD

Day Vol.

Previous Day Vol.

107882

Currency

USD

Primary Exchange

Nasdaq

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prelude Therapeutics Incorporated - Prelude Therapeutics’ SMARCA2 Degrader PRT3789 Demonstrated Promising Initial Clinical Activity and Safety Profile in Phase 1 Trial

Prelude Therapeutics announced positive initial clinical data for its SMARCA2 degrader PRT3789 in a Phase 1 trial, showing promising anti-tumor activity and a generally well-tolerated safety profile in patients with SMARCA4-mutated cancers.

Related tickers: PRLD.

Read Full Article

Prelude Therapeutics, Inc. - Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.

Related tickers: PRLD.

Read Full Article

Trending Tickers

Please sign in to view